Taiwan
4 Vaccines Approved for Use in Taiwan
Protein Subunit
RNA
Moderna
Spikevax
Approved in 86 countries
63 trials in 22 countries
Approval Source: taiwannews.com.tw
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
80 trials in 26 countries
Approval Source: cdc.gov.tw
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
63 trials in 30 countries
Approval Source: reuters.com
7 in Clinical Trials in Taiwan
Protein Subunit
COVAXX
UB-612
7 trials in 2 countries
Protein Subunit
Medigen
MVC-COV1901
Approved in 3 countries
14 trials in 4 countries
RNA
Moderna
Spikevax
Approved in 86 countries
63 trials in 22 countries
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
80 trials in 26 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
63 trials in 30 countries
Protein Subunit
Adimmune Corporation
AdimrSC-2f
3 trials in 2 countries
Protein Subunit
Medigen